Lexaria Bioscience Corp. — Director's Dealing 2023

Jul 25, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2023-07-25

Reporting Person: TURKEL CATHERINE C. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-25	Stock Options	$0.87	A	5000	Acquired	2028-07-25	Common Shares (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	1500	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$3.04	2027-09-02	Common Shares (3400)	3400	Direct
Stock Options	$1.96	2027-10-12	Common Shares (1600)	5000	Direct